Due to poor air quality, the Academy San Francisco offices will be closed Friday, Nov. 16. 

    AGS 2017
    Glaucoma, Surgical Management

    Cyclophotocoagulation (CPC) is an effective form of cycloablative therapy, but it has been associated with numerous risks and considered a treatment of last resort. Dr. Jonathan Myers discusses the Micropulse (Iridex), a new transscleral diode laser CPC platform that appears to have a better safety profile than its predecessor. The Micropulse shows good pressure reduction and success rates ranging from 50% to 80%. The incidence of reported side effects is low, with cystoid macular edema and loss of 2 or more lines of BCVA the most common.